Jean Manson

Prof. Manson is an internationally recognised leading scientist in TSE research and has developed, delivered and managed a high international scientific programme involving studies of animal and human Transmissible Spongiform Encephalopathies (TSEs). She develops and uses in vivo and in vitro model systems to define the basic mechanisms of disease and to address practical issues involving the TSEs. She heads a division of six group leaders and forty scientific staff all researching TSEs. She...See more

Prof. Manson is an internationally recognised leading scientist in TSE research and has developed, delivered and managed a high international scientific programme involving studies of animal and human Transmissible Spongiform Encephalopathies (TSEs). She develops and uses in vivo and in vitro model systems to define the basic mechanisms of disease and to address practical issues involving the TSEs. She heads a division of six group leaders and forty scientific staff all researching TSEs. She also runs a research group of seventeen people, including postdocs, technicians and PhD students. The transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases affecting humans and animals. TSEs present with characteristic pathology which can include neuronal loss, reactive astrogliosis, deposition of disease-associated prion protein (PrP) and vacuolation in the brain. The aim of her group is to examine the role of host PrP in TSEs such as scrapie, bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease (CJD), the nature of the infectious and neurotoxic agent and to define routes of transmission between and within animal Basic research into neurodegenerative processes has also led into study of other diseases such as Alzheimer's disease. They use a variety of models from the molecular to whole animal level of study. They have produced a number of unique transgenic mouse models via gene-targeting and with these models we are investigating the effects of PrP sequence, the species barrier, the influence of PrP glycosylation on disease susceptibility and also the expression of PrP in various cell-types or at specific time-points during disease. The group also investigates human to human transmission of vCJD via blood transfusion and other potential routes. Their research programme currently receives funding from a number of different sources including BBSRC, MRC, DEFRA, DoH and EU. See less